期刊信息查詢系統

期刊標題檢索 CANCER NANOTECH 最新評論: Height increases quickly, the proof is also fast. However, the online ... (2022-05-30)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Cancer Nanotechnology]您好，您是該頁面的第 12769 位訪客。

期刊簡介

期刊名稱

Cancer Nanotechnology
LetPub Score

7.1

50 ratings

Rate

Reputation

8.3

Influence

6.1

Speed

7.1

期刊簡稱

CANCER NANOTECHNOL

ISSN

1868-6958

E-ISSN

1868-6966

h-index

N.A.

CiteScore

SJR

SNIP

CiteScore Rank

5.20

0.671

0.723

Subject field	Quartiles	Rank	Percentile
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Pharmaceutical Science	Q2	68 / 183
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Physical and Theoretical Chemistry	Q2	75 / 189
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Oncology	Q2	163 / 404
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Biomedical Engineering	Q2	128 / 303

自引率 (2023-2024)

4.40%自引率趨勢

掲載範囲

Aim:
Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.
Scope:
Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

官方網站

https://www.springer.com/journal/12645

在線稿件提交

https://www.editorialmanager.com/CANO

開放訪問

Yes

出版商

Springer Vienna

主題領域

Pharmacology, Toxicology and Pharmaceutics

出版國/地區

AUSTRIA

發行頻率

創刊年

2010

每年文章數

83每年文章數趨勢

黃金OA百分比

100.00%

OA Related Info

APC: Yes（ EUR1590; USD1890; GBP1340; ）
APC waiver：Check Notes
Other charges: No
Keywords: nanostructures、nanoscale processes、cancer
Useful LinksAims & Scope Author Instructions Editorial Board Anonymous peer review

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q1

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
NANOSCIENCE & NANOTECHNOLOGY	SCIE	Q2	61/140
ONCOLOGY	SCIE	Q1	78/322

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1868-6958%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: 15 Weeks

競爭力 *

來自作者的數據:

參考鏈接

相關期刊	【Cancer Nanotechnology】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
Asian Journal of Pharmaceutical Sciences	H-index: 27 CiteScore: 18.30
Bioengineering & Translational Medicine	H-index: 0 CiteScore: 8.40
Journal of Pharmaceutical Investigation	H-index: 0 CiteScore: 10.20
Pharmaceutics	H-index: 32 CiteScore: 7.90
Pharmaceuticals	H-index: 0 CiteScore: 6.10
Advanced Therapeutics	H-index: 0 CiteScore: 7.10
SCIENTIA PHARMACEUTICA	H-index: 0 CiteScore: 4.60
BioImpacts	H-index: 0 CiteScore: 4.80
Drug Metabolism Letters	H-index: 0 CiteScore: 2.80
Recent Patents on Drug Delivery and Formulation	H-index: 0 CiteScore: 2.30

學科內最受檢索的期刊	頁面查看次數
Pharmaceutics	120129
Pharmaceuticals	62876
Asian Journal of Pharmaceutical Sciences	56480
Bioengineering & Translational Medicine	33082
Advanced Therapeutics	26124
BioImpacts	6997
International Journal of Pharmaceutics: X	3318
Journal of Pharmaceutical Investigation	3270
Recent Patents on Drug Delivery and Formulation	2828
Drug Metabolism Letters	2697

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Cancer Nanotechnology] 的評論	撰寫評論

作者: sunnybitc 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2022-05-30 23:38:29 評論於 Height increases quickly, the proof is also fast. However, the online typesetting is relatively slow, and it is possible that it will not be published until three months later. The layout fee is 12,000, which is a bit expensive. The impact factor is expected to rise, and it feels okay. (0) 讚！ \| sunnybitc
作者: sunnybitc 領域: 医学審稿時間: 1.0 month(s) 結果: 待定＆不明撰寫評論	2022-01-07 10:21:24 評論於 The impact factor is good, and it is steadily increasing. I have submitted it and hope for good results. (1) 讚！ \| sunnybitc

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Cancer Nanotechnology] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: sunnybitc 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2022-05-30 23:38:29 評論於 Height increases quickly, the proof is also fast. However, the online typesetting is relatively slow, and it is possible that it will not be published until three months later. The layout fee is 12,000, which is a bit expensive. The impact factor is expected to rise, and it feels okay. (0) 讚！ \| sunnybitc
作者: sunnybitc 領域: 医学審稿時間: 1.0 month(s) 結果: 待定＆不明撰寫評論	2022-01-07 10:21:24 評論於 The impact factor is good, and it is steadily increasing. I have submitted it and hope for good results. (1) 讚！ \| sunnybitc

首頁上一頁 1 下一頁末頁 (頁 /1)

Cancer Nanotechnology

期刊標題檢索 CANCER NANOTECH 最新評論: Height increases quickly, the proof is also fast. However, the online ... (2022-05-30)

[Cancer Nanotechnology]您好，您是該頁面的第 12769 位訪客。

開始撰寫 [Cancer Nanotechnology] 的評論：

Contact us